Company Description

At Altoida we built a digital biomarker platform using smartphone sensors to measure cognitive outcomes. We are now deploying our FDA Class II Medical Device, Altoida NMI, for early Alzheimer’s Disease detection up to 6+ years before symptoms with an accuracy of 94%.